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Abstract: Highly crystalline titanium dioxide nanoparticles (TiO2-NPs) are synthesized via a simple
hydrothermal technique. After structural and compositional analysis, the as-synthesized unmodified
TiO2-NPs are tested for improvement in two modes of kilovoltage radiation therapy and single-
photon emission computed tomography (SPECT)/computed tomography (CT). Our results show
that the unmodified TiO2-NPs provide an observable enhancement in CT scan image contrast ranging
from 0 ± 3 HU (without NPs) to 283.7 ± 3 HU (0.23 g/mL). TiO2-NPs has excellent biocompatibility,
selective uptake at target sites, and reduced toxicity. The unmodified TiO2-NPs as a contrast agent
can significantly improve the existing methods of diagnosing and treating cancer.
Keywords: nanoparticles; titanium dioxide; highly crystalline; computed tomography
1. Introduction
Titanium dioxide nanoparticles (TiO2-NPs) are among the most widely used engi-
neered nanostructures of TiO2. Most of the TiO2 applications are due to their structural and
electronic properties. It consists of mainly three phases which included anatase, rutile, and
brookite [1]. Due to its greater photocatalytic activity [2], anatase has the highest number
of industrial applications compared to rutile and brookite [3]. At the beginning of the 20th
century, mass production of TiO2-NPs started as a non-toxic substitute for a white dye used
in paints. It has various applications in food colorant or white pigment in manufacturing
plastics, paper, ink, paints, and welding rod coating material. Ultrafine TiO2-NPs [4] are
widely used in other industrial products, such as cosmetics, toothpaste, pharmaceuticals,
and skincare products [3,5–7]. TiO2-NPs is an n-type semiconductor with a wide bandgap,
having various applications in wastewater treatments dye-sensitized solar cells, photoion-
ized devices, and lithium batteries [8]. TiO2-NPs have specific medicinal properties and
have been used in many biomedical applications such as artificial hips, dental implants,
bone plates, coatings, scaffolds, and also in gene and drug delivery systems.
Interest in the synthesis of TiO2-NPs and their applications are due to their biocom-
patibility [9–11], antimicrobial properties [12,13], high chemical stability, specific surface
area, and catalytic activity [14–16]. Because of the wide range of applications, TiO2-NPs
have considerable potential for human exposure. People can be exposed to these nanopar-
ticles through oral, respiratory, or dermal routes. TiO2-NPs have been used in the food
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industry since 1996 when the US Food and Drug Administration approved it as a food
supplement [17]. TiO2-NPs are also used for electrostatic properties in terms of electrostatic
potentials and ion distributions [18] for dye-degrading activities, H2O2 scavenging, and
anticoagulant activities [19] to enhance the glasses’ radiation protection properties along
with bioactive glasses [20] as nanocarriers for drug delivery [21] and as a nano-drug for
treating diseases [22]. The idea of agents for two modes of therapy enhancement and
image contrast is one field that remains largely unexplored. The principle of two modes
of enhancement agents has been validated for radiotherapy enhancement applications by
using conventional non-nanoparticle image contrast agents such as iodine [23–25].
There have been reports in which TiO2-NPs can be used in radiation therapy applica-
tions for the treatment of cancer due to their absorptive properties and higher refractive
index [23–26]. The tumor during radiotherapy is exposed to ionizing radiation. As a result,
it gives damage to the DNA of the tumor and other biological molecules and ultimately
results in the cell’s death.
The inescapable radiation dose administered to the surrounding healthy tissues of the
tumor being treated is the intrinsic drawback of radiation therapy. The use of radiotherapy
is restricted for some tumors, due to unwanted damage to the surrounding healthy tissue by
the dose required to destroy the tumor [27]. Cheng et al. investigated a hybrid anisotropic
nanostructure, composed of gold (Au) doped titanium dioxide (TiO2), as a radio-sensitizer
for radiotherapy of triple-negative breast cancer (TNBC) [28]. Liang et al. used TiO2 to
enhance the quantum yield in ultra-sound activated sonodynamic therapy (SDT) [29]. Yang
et al. synthesized carbon-doped titanium dioxide to generate ROS to eliminate tumor cells
under ultrasound irradiation [30]. Su et al. construct an active site in a TiO2 nano catalyst
by auger electrons (AEs) for cancer catalytic internal radiotherapy (CIRT) applications [31].
Contrast-enhanced radiotherapy (CERT) [32] requires injection of contrast agents to the
target volume with high-Z (high atomic number) and kilovoltage X-rays irradiation. Since
materials with a high Z content have different absorption properties from those of healthy
tissues, therefore the distribution of the absorbed dose can be changed due to their presence.
In areas where a contrast agent is present, an increase in localized dose can be obtained
without affecting the healthy tissue [23,24]. Kilovoltage X-rays energy range is considered
the ideal range for CERT [24] because the change in photo absorbing properties is noticeable
at kilovolt energies [32,33]. Some improvement has also been observed in contrast by using
X-ray energy in the megavolt range provided by medical linear accelerators (Linac) [34,35].
TiO2-NPs with a size in the range of smaller than 100 nm can penetrate the cell membrane
and preferably accumulate in cancer cells [36]. Moreover, it can work as the required
contrast agent.
Previously iodine has been used as a contrast agent for computed tomography (CT)
imaging [37]. A conventional CT scanner was used to monitor iodine uptake and tumor
progression simultaneously. The pioneer studies for photodynamic therapy and MRI
enhancement have missed or ignored the concept of nanoparticles-based enhancement
agents [38,39]. NPs synthesized for radiotherapy and ionizing radiation would be bene-
ficial to monitor them with CT scanners as it is the standard imaging tool for treatment
planning and diagnosis [40,41]. These CT scanners are gradually replacing the conven-
tional radiotherapy treatment planning simulator units. A conventional CT scanner may
also be updated to deliver therapeutic doses of X-rays by using iodine CERT [24,41]. The
dose distributions generated by this method is comparable to those obtained with 10 MV
therapy and allows simulation, hybrid imaging, and treatment on a similar mechanism [24].
A similar alternative would be highly desirable for more advanced contrast agents.
This alternative can be sought with TiO2-NPs because it has the potential to be used as
a contrast agent, radiotherapy enhancement agent, and have an anti-cancer effect. Although
various studies have examined the imaging properties of chemically modified TiO2-NPs,
the imaging properties of unmodified TiO2-NPs have not been studied. Thus, the current
study is based on the visibility of unmodified TiO2-NPs (synthesized by hydrothermal
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route) by using CT and kilovoltage X-ray unit to determine their image contrast and
radiation enhancement properties.
2. Materials and Methods
TiO2-NPs have been synthesized by using 3 g of commercial titanium dioxide (in
bulk). At room temperature, the bulk TiO2 is mixed with 80 mL of sodium hydroxide
(from 10 M aqueous solution) by vigorous stirring for 1.5 h. Afterward, it is placed in a
Teflon-lined autoclave and heated at 160 ◦C for 48 h. The resulting precipitate after cooling
down at room temperature is washed several times with diluted hydrochloric acid (0.1 M)
and deionized water and then dried at 120 ◦C in the oven for 2 h. The imaging capabilities
of the synthesized TiO2-NPs were investigated by inserting its solution at 1.5 cm depth
with the help of a cylindrical vial. Discovery NM/CT 670 pro (GE Healthcare) was used
to image these vials and the CT values of each vial are provided in Hounsfield units (the
standard unit for CT scans) [42]. The resulting values and concentration are plotted to
obtain a linear fit. The solutions on a WOmed T-200 kilovoltage X-ray therapy unit are
exposed to test their dose enhancement competencies. The solutions are mounted on the
phantom’s surface in plastic tubes so that the thickness of the nanoparticle solution was
0.5 cm. Radiation-sensitive radio chromic film (Gaphchromic EBT2) was positioned on the
solution’s surface in such a way that the radiation source was facing the active sheet. The
film was then exposed to the surface with a dosage of 1.00 Gy. To determine whether the
existence of nanoparticles enhances the dose, the dose reported by each piece of film was
plotted against the concentration of the nanoparticle.
3. Results
A field emission scanning electron microscope (FE-SEM) is used to observe the ap-
parent morphology of the as-synthesized TiO2-NPs. The obtained information about the
structure or morphology of the as-synthesized TiO2-NPs is shown in Figure 1. All the
TiO2-NPs seem like small spheres (nanospheres). The micrograph shows that almost all of
the TiO2-NPs are in the nanometer range. At the bottom, most of the smaller size particles
are closely packed alongside others. The smaller the size of the particle, the more at the
bottom it lies followed by a bit bigger, etc. In contrast, at the top, the larger size particles
are mostly seemed isolated from one another. It is an indication of the top-down approach
followed during the synthesis of TiO2-NPs. Nanoparticles of different sizes (smaller and
bigger) can be seen and observed in the current micrograph. Thus, the biggest particles in
the sample are placed at the top followed by the smaller and smallest at the bottom. This
observation further verifying the top-down approach followed during the synthesis of
TiO2-NPs. The FE-SEM results show that the average particle size is below 100 nm.
Figure 1. Field emission scanning electron microscope (FE-SEM) micrograph of the as-synthesized
titanium dioxide (TiO2) nanoparticles.
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X-ray diffraction pattern of the as-synthesized TiO2-NPs is shown in Figure 2. It is an
analytical technique used to identify the crystallinity and phase formation of TiO2-NPs.
The XRD study was conducted through the X-ray diffractometer at 298 K by using a nickel-
filtered Cu α radiations source (K = 1.5418) at 298 K. The intensity data was attained over a
2θ range of 10–80◦. The diffraction peaks were observed at the diffraction angle of 23.17◦,
25.71◦, 27.92◦, 36.57◦, 37.53◦, 38.32◦, 41.71◦, 48.52◦, 54.46◦, 55.51◦, 57.09◦, 69.30◦, 70.71◦,
and 75.48◦, respectively. The crystalline phases of TiO2-NPs were identified by X’Pert high
score by comparing it with the standard data JCPDS card no. 01-075-1537 (Anatase) and
01-082-0514 (Rutile). Accordingly, all the peaks correspond to (101), (110), (103), (004),
(112), (111), (200), (105), (211), (220), (116), (220), and (202) planes in the as-synthesized
TiO2. Debye Scherrer equation was used to measure the crystallite size of the synthesized
nanoparticles with the help of XRD data of all the prominent peaks according to which the
average crystallite size of TiO2-NPs was 20 nm.
Figure 2. X-ray diffraction pattern of TiO2.
Bonding properties, valence states, and quantitative analysis of the electronic struc-
tures of the synthesized TiO2-NPs were performed by X-ray photoelectron spectroscopy
(XPS). In the XPS analysis, Ti 2p and O 1s are observed and no other precursor elements
or magnetic contamination are found as shown in Figure 3. Moreover, the hydrocarbon
contamination (C 1s) peak is detected at approximately 285 eV [43]. The XPS survey with
the peaks tagged for the corresponding elements for their binding energies is shown in
Figure 3a. Two sharp peaks are observed in Figure 3b, which corresponded to the spin-
orbit of Ti 2p3/2 and Ti 2p1/2 at binding energies of 463 eV and 468 eV for Ti4+ in TiO2.
No obvious peak shift is observed. This shows that Ti atoms exist in the same oxidation
state [44]. The magnified O 1 s peak is shown in Figure 3c. The peak observed at 533 eV
is interpreted to be due to bulk oxygen in the TiO2 [45]. The full width at half maximum
(FWHM) is approximately similar in all spectra (1.35 eV). In Figure 3a, escorting to the
higher binding energy side of the peak involves many components resulting from TiO2
surface hydroxylation (when it is mounted the electrode is exposed to air). These are
attributable to both acidic and fundamental hydroxyl groups and absorbed water at the
outermost surface. We observe the O 1s spectrum similar to those recorded on untreated (as
grown) single crystal of anatase [46] and rutile exposed to vapor and liquid water [47,48].
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Figure 3. (a) XPS survey of the as-synthesized TiO2 nanoparticles, (b) high-resolution Ti 2p, and (c) O
1s XPS spectra.
Figure 4 shows the Raman spectrum of the as-synthesized TiO2-NPs. The intense
Eg mode appears at 143.7 cm−1 [49]. B1g, (A1g + B1g) and Eg peaks appear at 399 cm−1,
516 cm−1, and 637 cm–1 respectively. In TiO2 vibrational modes are due to the symmetric,
asymmetric, and bending vibration of the Ti–O–Ti bond [50,51]. The peak tagged by Eg
stands for Ti–O stretching mode, whereas the peaks located at 516 cm–1 and 399 cm–1
modes refer to Ti–O stretching mode (the only O is moving) and O–Ti–O bending mode
(Ti is moving) [51,52]. Phonons near the center of the Brillouin zone (BZ) contribute to the
inelastic dispersion of incident radiations only in a perfect infinite crystal. A greater part of
the BZ will efficiently participate in scattering processes as the size of the crystal vary in
the nanoscale due to the weakening of the selection rule at q0 ≈ 0. Thus, a change in the
Raman frequency peaks and the shape of the Raman band can be observed [53].
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Figure 4. Raman spectroscopy of titanium dioxide nanoparticles.
Figure 5 indicates the CT numbers of the different concentrations of TiO2-NPs that
were scanned. With the addition of NPs concentration, the CT numbers of the solutions
improve roughly linearly. The uncertainty of the measurements in the Hounsfield unit
(HU) is given by the standard deviation. The CT numbers were ranging from 0 ± 3 HU
(without NPs) to 283.7 ± 3 HU (0.235 g/mL). A value of (27.5 ± 3, 75.9 ± 3, 125.7 ± 3,
172.2 ± 3, 235.4 ± 3, and 283.7 ± 3) HU is given by a (0.02, 0.05, 0.1, 0.15, 0.2, 0.235) g/mL
concentration of NPs. This concentration is higher than the noise value typically reported
by most CT scanners of about 5 HU [37]. These findings show that the existence of TiO2-
NPs even at low concentrations induces observable variations in the scanned media that
can be observed on a traditional CT scanner.
Figure 5. Computed tomography (CT) numbers of TiO2-NPs solution as a function of concentration.
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In Figures 6 and 7, the surface doses are reported as a function of NPs concentration
by the EBT2 film pieces. The enhancement is not observed at surface dose for both energies.
The measured dose is maximum in both cases only for the solution having no NPs. The
measured dose at 50 kVp falls approximately linearly with the concentration of NPs.
Changes found during measurements of dose for all concentrations of NPs within 4% of
the measurement error for a beam energy of 125 kVp. For the vial that does not contain
nanoparticles, none of the obtained values reflects more than 97% of the dose measured.
The decrease in surface dose at higher concentrations of NPs can be associated with the
absorption of backscattered radiation by the solution of NPs near the surface without a
sequential increase in the dose to compensate for this.
Figure 6. Normalized surface dose as a function of nanoparticle concentration recorded for the
125 kVp radiation beams.
Figure 7. Normalized surface dose as a function of nanoparticle concentration recorded for the
50 kVp radiation beams.
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4. Conclusions
TiO2-NPs were synthesized by the hydrothermal route and used in CT and kilovoltage
X-ray unit for contrast enhancement properties. The CT numbers were ranging from
0 ± 3 HU (without NPs) to 283.7 ± 3 HU (0.235 g/mL). For each measurement, the
uncertainty is within 3 HU. Our initial findings for titanium dioxide nanoparticles as
potential two modes imaging and enhancement agents for therapy suggest that they are a
promising contender for image contrast in computed tomography and will be used as a
potential anti-tumor agent in drug delivery systems. It has been found that our synthesized
highly crystalline unmodified titanium dioxide nanoparticles have an immense potential
to improve the existed techniques for cancer imaging and treatment. Bearing impressive
results in existing techniques of imaging, there is now increasing curiosity for the potential
applications of crystalline unmodified titanium dioxide nanoparticles to radiotherapy and
photodynamic therapy. Both of these techniques will bring substantial improvements in
the effectiveness of existing cancer treatments in the near future.
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